
Taiwan Targets Blood-Bag Production as China Steps Up Pressure
Taiwan aims to start producing its own blood bags — a key item for saving lives on the battlefield — adding to signs President Lai Ching-te is stepping up preparations for a potential conflict with China.
The Health Ministry has been working closely with other government agencies, including the National Security Council, to enhance Taiwan's medical preparedness for emergencies, Deputy Health Minister Lin Ching-yi told Bloomberg News. Strengthening domestic production capacity for key medical supplies, including blood bags, is a part of the strategy, she said, as was ensuring that imports of medical supplies were secure.
'The Covid-19 pandemic and the war in Ukraine have underscored the risks of relying solely on foreign sources for essential medicines and medical equipment,' Lin said. Ukraine's health-care resources have been strained during its fighting with Russia, leading to shortages of oxygen, medications and more.
Lai has made preparing the self-ruled archipelago of 23 million people for a possible conflict with China a central part of his policymaking since he took office a little more than a year ago. Last year, he held the first meeting of a civil defense committee that discussed ways to make sure key energy facilities and critical infrastructure can operate in a crisis.
China views Taiwan as part of its territory that must be brought under its control someday, by force if necessary. The People's Liberation Army has held an unprecedented amount of military exercises around Taiwan since Lai took over, underscoring its deep distrust of a leader it worries will formalize Taiwan's independence.
Officials in Taipei downplay the likelihood of a conflict with China anytime soon, though US Defense Secretary Pete Hegseth recently warned more urgency is needed to prepare for a potential People's Liberation Army invasion.
From at least last year, the US — Taipei's main military backer — started raising concern about the archipelago's blood reserves and distribution capabilities, according to Taiwanese officials familiar with the matter, who asked not to be identified discussing the sensitive matter.
Specific issues included whether Taiwan had enough electricity supplies and backup power systems for blood banks, one of the officials said. The US was also worried about adequate cold-chain logistics and storage, the person added.
In a report to lawmakers in March, the Defense Ministry in Taipei said that it planned to establish its first blood donation center by the end this year. A program to create a centrally managed blood supply system would be set up in 2026, it added.
Lin said Taiwan relies on imports for its supply of blood bags because that is cheaper than making them domestically. Blood bags are containers primarily made of medical-grade PVC that are used in the collection, storage and transfusion of blood. A ready supply is critical in wartime, and would help save the lives of soldiers in Taiwan's military, which is much smaller than China's.
Taiwan's National Security Council declined to comment on Tuesday on the push to improve medical preparedness.
Nan Ya Plastics Corp., a subsidiary of Taiwan's largest petrochemical conglomerate, Formosa Plastics Group, has built the archipelago's first blood bag factory near Taipei, Economic Daily News reported, citing a person at a firm that cooperates with Nan Ya Plastics on the plant.
It is in the process of applying for a certificate to produce the containers, EDN said in a separate report that cited comments Nan Ya Plastics chairman Wu Chia-chau made at an annual general meeting last week.
Nan Ya Plastics didn't immediately respond to a request for comment.
With assistance from Miaojung Lin.
This article was generated from an automated news agency feed without modifications to text.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
an hour ago
- Hans India
Trump departs G-7 summit unexpectedly as rumors swirl about potential U.S. strike on Iranian nuclear sites
G7 2025 Trump news: US President Donald Trump left abruptly the Trump G7 exit in Calgary, Monday evening, to deal with security-related issues in the US Iran tensions. This ruined a bilateral meeting planned between Trump and Prime Minister Narendra Modi who had arrived at the summit just as Trump's departure announcement was made. Trump was only at the summit less than 24 hours when he abruptly left. White House spokesperson Karoline Leavitt said that "much has been accomplished but due to what is happening in the Middle East President Trump will leave tonight after dinner with the Heads of States." Trump had earlier alarmed the world with his post saying: "Everyone should evacuate Teheran immediately" and at the end of the post he said, "Iran should've signed the "deal" I told them to. What a waste of human lives and a shame. IRAN CANNOT HAVE A NUCLEAR WAR. "I said it again and again!" Trump is expected straight to a National Security Council Meeting in the Situation Room of the White House when he arrives. This comes amid speculations that the US would join Israel in an attack on Iranian nuclear facility program by dropping a bunker busted from American B-2 bombers, the only weapon that could destroy the deep-buried nuclear enrichment plant at Fordo. The 20 foot long GBU-57 bunker-buster, also known as the Massive Ordnance Penetrator or GBU-57 can only be lifted by a B-2 Bomber. Israel, despite being a close US ally, does not have either of these aircraft. Experts believe that the US will need to use multiple GBU-57s in order to enclose Fordo. War hawks view this as the only effective way to stop Iran's pursuit for a nuclear bomb. Anything less will allow Iran's pursuit of bunker-buster strike to continue.
&w=3840&q=100)

First Post
2 hours ago
- First Post
Covid in India: Death toll crosses 100 in current wave, Kerala leads national caseload
On Monday, 11 deaths were recorded, taking the total number of deaths to 108. While seven of these deaths were from Kerala, one each occurred in Delhi, Maharashtra, Chhattisgarh and Madhya Pradesh read more A doctor inspects an isolation ward prepared for the patients with Covid-19 symptoms at a government hospital in Secunderabad in Telangana. AFP Covid-19 death toll in India has crossed the 100-mark, with most fatalities reported in Kerala, which has been worst affected by the recent wave of cases. On Monday, 11 deaths were recorded, taking the total number of deaths to 108. While seven of these deaths were from Kerala, one each occurred in Delhi, Maharashtra, Chhattisgarh and Madhya Pradesh. The seven victims from Kerala were all over 60 and had underlying health conditions, including cancer, pancreatitis, kidney disease, and pneumonia. The victim from Delhi was a 67-year-old man with a history of lung cancer. STORY CONTINUES BELOW THIS AD Kerala currently has the maximum number of active cases at 1,920, followed by Gujarat at 1,433, Delhi at 649 and Maharashtra at 540. The current surge in cases is suspected to be driven by the emergence of new coronavirus sub-variants capable of evading immunity from previous infections and vaccinations. However, experts note that these variants are not causing severe symptoms. The subvariant JN.1 is making up 16.3 per cent of sequenced cases in the epidemiological week ending February 2. Authorities in Singapore have reported that two JN.1 descendant lineages, LF.7 and NB.1.8, now account for over two-thirds of locally sequenced cases. However, they clarified that 'there is no indication that the variants circulating locally are more transmissible or cause more severe disease compared to previously circulating variants.' While the rampant spread of the virus has been kept in check for a long time, SARS-CoV-2, the virus responsible for Covid-19, has not disappeared entirely. Earlier this month, when a rise in cases was being reported in Singapore, authorities said that periodic waves of Covid-19 can be expected throughout the year.


India Today
2 hours ago
- India Today
Israel Iran conflict Live: Trump calls Situation Room meeting with national security staff
The ongoing Iran-Israel conflict disrupted US President Donald Trump's G7 summit in Canada, forcing him to return to Washington DC to lead a National Security Council meeting he had convened.